| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |